Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung and Serum Responses to PCV7 in Malawian Adults
NCT00371878Phase 4Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Feb 2003
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label trial of pneumococcal 7-valent conjugate vaccine in pneumonia, meningitis and invasive pneumococcal disease (IPD) (2 arms), sponsored by Royal Liverpool University Hospital. Primary endpoint: Immunoglobulin titres in bronchoalveolar fluid. Started Feb 2003; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumoniameningitisinvasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT00371878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371878.